Katherine Ehrenreich is a Project Manager for a variety of studies that aim to expand access to medication abortion through alternative methods of provision, including over-the-counter access. Katherine has a background in qualitative research design and analysis, and is interested in people's sexual and reproductive health decision-making experiences. Previously, she worked for Population Services International (PSI) in Laos on program implementation for the Women's Health Project, and as an intern to the World Health Organization's Maternal and Child Health Unit. Katherine received her BA in Anthropology from Macalester College and her MSc in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.
April 25, 2023
Ehrenreich K, Baba F, Raifman S, Grossman D. Perspectives on Alternative Models of Medication Abortion Provision Among Abortion Patients in the United States. Women's Health Issues. April 2023; https://doi.org/10.1016/j.whi.2023.03.007.
April 17, 2023
Ralph LJ, Biggs MA, Ehrenreich K, Grossman D. Accuracy of Self-assessment of Gestational Duration Among Adolescents Seeking Abortion Using Information in Addition to Date of Last Menstrual Period. JAMA Pediatrics. April 2023; https://doi.org/10.1001/jamapediatrics.2023.0483.
February 22, 2023
Natalie Morris, MPH, Ehrenreich K, Gurazada T, Grossman D. Feasibility and Acceptability of At-Home Routine Pregnancy Testing in the United States: A Pilot Study. Women's Health Issues. February 2023; https://doi.org/10.1016/j.whi.2023.01.002.
October 4, 2022
Ehrenreich K, Kimport K. Prenatal Care as a Gateway to Other Health Care: A Qualitative Study. Women's Health Issues. October 2022; DOI: 10.1016/j.whi.2022.08.006.
August 12, 2022
Ralph LJ, Ehrenreich K, Kaller S, Biggs MA. A cross-sectional study examining consideration of self-managed abortion among people seeking facility-based care in the United States. Reproductive Health. August 2022; DOI: 10.1186/s12978-022-01486-8.
May 5, 2022
Biggs MA, Ehrenreich K, Natalie Morris, MPH, Blanchard K, Bustamante CK, Choimorrow SY, Hauser D, Hernandez Y, Kapp N, Kromenaker T, Moayedi G, Perritt J, Ralph LJ, Raymond EG, Valladares ES, Kari White, Grossman D. Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product. Obstetrics & Gynecology. May 2022; DOI: 10.1097/AOG.0000000000004757.